Specialty Diagnostic Device Leader Deploys QAD Enterprise Applications on Demand

Alpine Biomed Creates Platform to Support Rapid Growth with QAD Software as a Service (SaaS) Offering

SANTA BARBARA, Calif.--(BUSINESS WIRE)--QAD, Inc (Nasdaq:QADI - News), a leading provider of enterprise software and services for global manufacturers, announced today that Alpine Biomed, a global leader in specialty diagnostic devices, has chosen to implement QAD Enterprise Applications using QAD On Demand Solutions — QAD’s Software-as-a-Service (SaaS) offering. Alpine Biomed designs, manufacturers and distributes diagnostic equipment and accessories for the gastroenterology and neurology clinical markets.

Alpine Biomed selected QAD’s Life Science Vertical Business Solution coupled with QAD’s Service and Support Solution delivered through QAD On Demand SaaS model to support its strategic growth objectives and maintain a lean, focused IT organization. “Alpine is achieving rapid growth and expansion of our business through a combination of organic growth and acquisitions. The QAD On Demand offering provides us with a comprehensive system, that can integrate new acquisitions and joint ventures rapidly,” said Cliff Oman, chief information officer for Alpine Biomed. “It enables us to continue operating as a lean and efficient team that can focus our time and talent on Alpine Biomed’s long-term, strategic vision. And, because of QAD’s industry acumen for the life sciences marketplace, we were able to implement the ERP system very quickly.”

“Today’s leading health care manufacturing companies need enterprise solutions that provide the utmost agility for the rapidly shifting global marketplace. QAD On Demand Solutions give companies like Alpine one of the best enterprise applications suite available, with the ease and convenience of on-demand delivery,” said Pam Lopker, president and founder of QAD. “Global manufacturers can leverage the industry-focused features and functionality in QAD Enterprise Applications to drive growth and profitability. QAD On Demand Solutions support our vision for the Perfect Lean Market, disseminating Lean concepts and practices throughout the extended enterprise.”

Alpine Biomed has worked closely with QAD Global Services throughout the project. “We’ve been pleased with the results our teams have achieved together to date. For example, we set up 32 global printers within a day of submitting a ticket. Prior to working with QAD, it would have taken much longer to complete,” said Oman. Alpine Biomed kicked off its QAD On Demand implementation in early April 2008, and is on target to take the entire company live this fall. “Leveraging on-demand deployment streamlined a lot of the issues that typically slow down implementations. We saved at least two months of set-up time on the front end of the project. With every line item, we’ve saved significant time,” said Oman.

QAD Enterprise Applications are designed to streamline the management of manufacturing operations, supply chains, financials, customers, technology, and business performance all in one suite. Built on a deep, foundational understanding of manufacturing and designed for maximum flexibility anywhere in the world, QAD Enterprise Applications are available in 27 languages and can handle multiple currencies. For both single-site manufacturers with customers and suppliers in many locations around the world, and global enterprises with factories and plants in dozens of countries, QAD can provide the solutions and support to operate multi-national businesses efficiently and profitably.

QAD On Demand

QAD On Demand is a delivery model that reduces a company's total cost of ownership and dramatically simplifies management of their QAD Enterprise Applications. QAD On Demand is available on a subscription basis or in a hosted/managed environment, enabling customers to better mange the uncertainty, risk and often unpredictable expense surrounding delivery, maintenance and upgrades of mission-critical applications.

About Alpine Biomed

Alpine Biomed is a global leader in specialty diagnostic devices for the gastroenterology and neurology clinical markets. The company produces diagnostic tools used for gastroesophageal reflux disease (GERD), commonly referred to as acid reflux disease, as well as for neurological conditions, such as carpal tunnel syndrome and sleep disorders. Founded in 1994, Alpine Biomed is headquartered in Fountain Valley, California with manufacturing facilities in Denmark, the United States and Vietnam. For more information about Alpine Biomed, visit www.alpinebiomed.com.

About QAD

QAD is a leading provider of enterprise applications for global manufacturing companies. QAD applications provide critical functionality for managing manufacturing resources and operations within and beyond the enterprise, enabling global manufacturers to collaborate with their customers, suppliers and partners to make and deliver the right product, at the right cost and at the right time. Manufacturers of automotive, consumer products, electronics, food and beverage, industrial and life science products use QAD applications at approximately 6,100 licensed sites in more than 90 countries and in as many as 27 languages. For more information about QAD, telephone +1 805 684 6614, or visit the QAD Web site at www.qad.com.

"QAD" is a registered trademark of QAD Inc. All other products or company names herein may be trademarks of their respective owners.

Note to Investors:

This press release contains certain forward-looking statements made under the "safe harbor" provisions of the Private Securities Litigation Reform Act of 1995. A number of risks and uncertainties could cause actual results to differ materially from those in the forward-looking statements. These risks include, but are not limited to, evolving demand for the company's software products and products that operate with the company's products; the company's ability to sustain license and service demand; the company's ability to leverage changes in technology; the company's ability to sustain customer renewal rates at current levels; the publication of opinions by industry and financial analysts about the company, its products and technology; the reliability of estimates of transaction and integration costs and benefits; the entry of new competitors or new offerings by existing competitors and the associated announcement of new products and technological advances by them; delays in localizing the company's products for new or existing markets; the ability to recruit and retain key personnel; delays in sales as a result of lengthy sales cycles; changes in operating expenses, pricing, timing of new product releases, the method of product distribution or product mix; timely and effective integration of newly acquired businesses; general economic conditions; exchange rate fluctuations; and, the global political environment. In addition, revenue and earnings in the enterprise resource planning (ERP) software industry are subject to fluctuations. Software license revenue, in particular, is subject to variability with a significant proportion of revenue earned in the last month of each quarter. Given the high margins associated with license revenue, modest fluctuations can have a substantial impact on net income. Investors should not use any one quarter's results as a benchmark for future performance. For a more detailed description of the risk factors associated with the company and the industries in which it operates, please refer to the company's Annual Report on Form 10-K for fiscal 2008 ended January 31, 2008.

Printer Friendly

Email Page

Sponsor Message